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Oxidative damageNeuroferritinopathy is a rare genetic diseasewith a dominant autosomal transmission caused bymutations of the
ferritin light chain gene (FTL). It belongs to Neurodegeneration with Brain Iron Accumulation, a group of disor-
ders where iron dysregulation is tightly associated with neurodegeneration. We studied the 498–499InsTC mu-
tation which causes the substitution of the last 9 amino acids and an elongation of extra 16 amino acids at the
C-terminus of L-ferritin peptide. An analysis with cyclic voltammetry on the puriﬁed protein showed that this
structural modiﬁcation severely reduces the ability of the protein to store iron. In order to analyze the impact
of the mutation in vivo, we generated mouse models for the some pathogenic human FTL gene in FVB and
C57BL/6J strains.
Transgenic mice in the FVB background showed high accumulation of the mutated ferritin in brain where it cor-
relatedwith increased iron deposition with age, as scored bymagnetic resonance imaging. Notably, the accumu-
lation of iron–ferritin bodies was accompanied by signs of oxidative damage. In the C57BL/6 background, both
the expression of the mutant ferritin and the iron levels were lower than in the FVB strain. Nevertheless, also
these mice showed oxidative alterations in the brain. Furthermore, post-natal hippocampal neurons obtained
from thesemice experienced amarked increased cell death in response to chronic iron overload and/or acute ox-
idative stress, in comparison to wild-type neurons. Ultrastructural analyses revealed an accumulation of
lipofuscin granules associated with iron deposits, particularly enriched in the cerebellum and striatum of our
transgenic mice. Finally, experimental subjects were tested throughout development and aging at 2-, 8- and
18-months for behavioral phenotype. Rotarod test revealed a progressive impaired motor coordination building
upwith age, FTLmutant old mice showing a shorter latency to fall from the apparatus, according to higher accu-
mulation of iron aggregates in the striatum. Our data show that our 498–499InsTC mouse models recapitulate
early pathological and clinical traits of the human neuroferritinopathy, thus providing a valuable model for the
study of the disease. Finally, we propose a mechanistic model of lipofuscine formation that can account for the
etiopathogenesis of human neuroferritinopathy.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ht chain gene; FtL, ferritin light
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Iron dyshomeostasis is often associatedwith neurodegenerative dis-
eases (Rouault, 2013; Vidal et al., 2008), however whether it is a prima-
ry cause of the neurodegenerative process or a secondary effect is still
debated (Levi and Finazzi, 2014). An opportunity to investigate the
iron involvement in neurodegenerative processes is the group of dis-
eases, referred to as “Neurodegenerationwith Brain Iron Accumulation”the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
athy mouse model (FTL 498InsTC) shows progressive brain iron...,
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autopsy ﬁndings reveal focal iron accumulation in speciﬁc regions of
the brain. Neuroferritinopathy (NF) (or NBIA3, OMIM, 606159) belongs
to this group of diseases. It is classiﬁed as an adult-onset extrapyramidal
disorder, in which motor symptoms prevail, while cognitive decline is
uncommon or very mild. NF is a rare autosomal dominant disease
caused by mutations in exons 3 and 4 of the ferritin light chain (FTL)
gene (Curtis et al., 2001; Muhoberac and Vidal, 2013).
Ferritin is an iron storage protein able to detoxify cells from the
redox-active free iron, that exists in a prevalent cytosolic form and in
a minor mitochondrial one (Arosio and Levi, 2010). The cytosolic
ferritin is composed of 24 subunits that co-assemble in heteropolymers
of H- and L-chains. The H chain has a ferroxidase activity that is neces-
sary for ferric iron incorporation,while the L-chain assists and facilitates
the nucleation of the ferric iron inside the cavity (Arosio and Levi, 2010).
Until now, sevenmutations responsible for NFwere identiﬁed. Only one
is a missensemutation in exon 3 of FTL found in a single subject (Maciel
et al., 2005) and its causative role is dubious; all the other ones are nu-
cleotide insertion that strongly modify the C-terminus of the L-chain
(Curtis et al., 2001; Vidal et al., 2004; Mancuso et al., 2005; Devos
et al., 2009; Ohta and Takiyama, 2012; Kubota et al., 2009; Nishida
et al., 2014). The C-terminus is rich of inter-chain contacts connecting
four subunits at the 4-fold symmetry axis that participate to protein as-
sembly (Luscieti et al., 2010). It has been demonstrated that NF muta-
tions reduce ferritin stability as well as its ability to retain iron within
the cavity, and that they act in a dominant negative manner even
when present in a low proportions, 2–3 subunits in the 24-mer shells
(Luscieti et al., 2010; Cozzi et al., 2010). Actually, the nucleotide inser-
tions/duplications alter the terminal part of the ferritin, the extent de-
pending on the site of insertion. Notably, it was indicated that onset
and severity of the disease correlate with the degree of alteration of
the protein (Kubota et al., 2009). The mutants are ubiquitously
expressed but the main pathological effects are observed in the brain
and more speciﬁcally in the basal ganglia, where neurons seem to
have a higher susceptibility. The 460InsA mutation was the ﬁrst to be
identiﬁed in a large number of families in West Anglia and, clinically,
is the best characterized form of NF (Curtis et al., 2001). However,
most of the experimental research on in vitro and animal models has
been concentrated on the insertion of TC nucleotides in FTL gene
(498–499InsTCmutation, analogous to the 497–498dupTC) that coding
for a variant protein with the substitution of the last 9 amino acids and
an extension of further 16 amino acids, which is biochemically more
stable than the 460InsA mutant (Muhoberac and Vidal, 2013). These
studies reported a reduction in the iron storage capacity of ferritin as
well as the formation of ferritin aggregates, suggesting that these
features might concur to the pathogenetic events of the disease
(Baraibar et al., 2008). Other data support and extend these observa-
tions by providing evidence of oxidative damage in cells expressing
two pathogenic L-ferritin variants in cell lines (460InsA and 498–
499InsTC) (Cozzi et al., 2010, 2006) and in ﬁbroblasts derived from a
NF patient with 498–499InsTC mutation (Barbeito et al., 2010).
The only animal model of the disorder produced so far is a
transgenic mouse overexpressing the 498–499InsTC human ferritin
mutant (Vidal et al., 2008). These mice were reported to show
nuclear and cytoplasmic aggregates of ferritin throughout the CNS
and in other organs, a progressive neurological phenotype, a
decreased mobility and a reduced life expectancy as well as an
increase in the amount of iron in brain, with altered levels of the
iron-related proteins (Vidal et al., 2008). Analysis of brain tissues
from these mice indicated an accumulation of oxidized DNA in
the mitochondria but no signiﬁcant damage to the nuclear DNA
(Deng et al., 2010); moreover, oxidative stress markers such as
protein carbonylation and lipid peroxidation were reported
(Barbeito et al., 2009).
Here we report a comprehensive study of the 498–499InsTC
human ferritin mutants that includes: i) an electrochemical analysisPlease cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
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deﬁnes functional alterations of the protein expressed in our mutant
mice; ii) a thorough characterization of our transgenic model, which
re-evaluates and extends biochemical, morphological and physio-
logical defects; iii) a behavioral investigation of these mice, which
formerly proves the pathologic effect of the expression of the mutat-
ed ferritin in aged subjects. Overall, our data further extend and
redeﬁne the knowledge of the effects exerted by mutated ferritin
on cellular iron handling and, more speciﬁcally, on the neuronal
susceptibility to oxidative stress and motor coordination deﬁcit.
Material and methods
Generation of FTL-498InsTC transgenic mice
The human FTL cDNA bearing the 498–499InsTC mutation
(Cozzi et al., 2006) was subcloned into the BamH1–XbaI site
between the PGK promoter and the SV40 poly-adenylation signal
of the pCCL.sin.cPPT.hPGK vector (Follenzi et al., 2000). The correct
assembly of the construct was ﬁrstly veriﬁed by restriction mapping
and then conﬁrmed by DNA sequencing (data not shown). The trans-
gene was excised from the vector by SﬁI-HpaI restriction digestion
and puriﬁed by gel extraction with the QIAEX II Gel Extraction Kit
(Qiagen, Hilden, Germany) Transgenic mice were generated by pro-
nuclear microinjection of the linearized fragment (shown in Fig. 1S
panel A) into fertilized mouse eggs from the FVB/N mouse strain.
Microinjection and egg implantation procedures were carried out
at the Core Facility for Conditional Mutagenesis (CFCM) Unit at the
San Raffaele Scientiﬁc Institute, Milano, Italy. Screening for the
correct insertion of the transgene was carried out by PCR ampliﬁca-
tion of the FTL1 gene. To this purpose, tail DNA was puriﬁed from
offsprings of matings of the heterozygous founders with wild-type
mice and ampliﬁed with the following combination of primers
which were speciﬁcally designed to amplify a fragment of the
human FTL1 cDNA: forward primer (5′-GTCTCCTGAAGATGCAAAAC
CAG-3′) and reverse primer (5′-AACCTCCACAGGCTGGGT-3′). The
ampliﬁcation product for construct insertion was of 275 bps
(Fig. 1S B). One independent line of the FTL-498InsTC FVB mice was
chosen for stable expression of the transgene, as assayed by Western
blotting of the non-denaturated protein with the anti-human FtL
mouse monoclonal-Ab (LF03, not shown). This FTL-498InsTC line was
backcrossed with C57BL/6J (C57) mice (purchased from Harlan Labora-
tories Srl, Udine, Italy) for N6 generations for generating mice suitable
for behavioral studies.
Transgenicmicewere bred and housed under a 12 h light–dark cycle
with free access to food and water.
Tissue preparations
Biochemical analysis was performed on FVB strain at different ages:
3, 6, 12, 18, 22 months-old. For each agewere analyzedWT (n=2male
and 1 female) and Tg (n= 2male and 1 female). C57 mice were tested
at 6,12,18 months-old (n = 2 male and 2 female) and Tg (n = 2 male
and 2 female).
Mice were anesthetized with Avertine (23 μl/g mouse; Sigma)
and perfused with a physiological saline solution containing 2% hep-
arin; tissue samples were then removed and: i) immediately frozen
for biochemical analysis; ii) immersed in PBS containing 4% parafor-
maldehyde 18 h for ex vivo MRI, immunoﬂuorescence and Prussian
Blue staining; iii) or immersed in PBS containing 4% paraformalde-
hyde and 2.5% glutaraldehyde for electron microscopy.
For biochemical analysis tissues were lysed in ice-cold lysis buffer
(20 mM Tris buffer, pH 7.4, 1% Triton X-100, 1 mM Na azide, 1 mM
PMSF, 10 mM leupeptin, 1 mM pepstatin) using a Potter homogenizer.
The homogenate was clariﬁed by centrifugation at 10,000 g for 10 minathy mouse model (FTL 498InsTC) shows progressive brain iron...,
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ELISA experiments.
For histochemistry and immunoﬂuorescence experiments brains
were incubated in PBS containing 4% of paraformaldehyde for 18 h,
then, were washed with PBS and included in agarose (4% in PBS)
for sectioning. Coronal slices of 40 μm were done with a Cryostate
and, then, cryopreserved in a solution composed of 30% glycol
ethylene, 30% glycerol and 40% PBS at−20 °C.
For electron microscopy analysis small pieces of ﬁxed brains were
dehydrated and embedded in Epon 812. Sections were cut with a
diamond knife by an Ultracut UCT (Leica Microsystem, Wetzlar,
Germany) and double stained with uranyl acetate and lead citrate
Ferritin quantiﬁcation and protein immunodetection
Transgenic human ferritin levels were determined on Architect
equipment of Abbot with reagents for the immunological determina-
tion of serum ferritin. We veriﬁed that the ELISA assay is speciﬁc for
human L ferritin with no cross reaction with mouse ferritins.
Endogenous L- and H-ferritins were quantiﬁed by ELISA using
speciﬁc rabbit polyclonals antibodies, E17 and Z17 respectively
calibrated on the corresponding recombinant homopolymer
(Santambrogio et al., 2007). Protein concentration was evaluated
by the bicinchoninic acid (BCA) method (Pierce) calibrated on BSA.
The expression of the transgene was also conﬁrmed by western blot-
ting. 20 μg of soluble proteins were heated at 70 °C for 10 min, cen-
trifuged at 13,000 rpm at 4 °C and the supernatants were separated
by non-denaturing-PAGE (native-PAGE). Immunoblotting was per-
formed using a speciﬁc antibody for human L ferritin (mouse mono-
clonal LF03) (Cozzi et al., 2006). To study iron incorporation
capacity, equal amounts of the 70 °C heated samples were separated
on native-PAGE and then the gels were stained with Prussian Blue
and enhanced with 0.025% 3,3′-diaminobenzidine (DAB) and 0.05%
H2O2 for 15min. The expression of other proteins was assayed by an-
alyzing 20 μg of homogenate soluble proteins separated by sodium
dodecyl sulfate -PAGE (SDS-PAGE) and immunoblotting was per-
formed using speciﬁc antibodies for Catalase (EMD, Millipore), TfR1
(Zymed), Ubiquitin (Santa Cruz Biotechnology) and β-actin (Sigma),
followed by peroxidase-labeled secondary antibodies (Sigma-Aldrich).
Band intensity was revealed by enhanced chemiluminescence (ECL; GE
Healthcare).
Detection of protein, lipid and DNA oxidation
The following kits were used according to manufacturer's
instructions:
– Oxidized proteins were revealed by the Oxyblot Protein Oxida-
tion Detection Kit (EMD Millipore). In brief, the soluble protein
extracts were derivatized to 2,4-dinitrophenylhydrazone (DNP),
and 1 μg was loaded on 12% SDS-PAGE, blotted and incubated
with an anti-DNP antibody, followed by an HRP conjugated
secondary antibody. The bound activity was revealed by ECL
advance (GE Healthcare).
– Lipid peroxidation was revealed by the OxiSelect MDA Immunoblot
Kit (Cell Biolabs, Inc). In brief, 10 μg of the soluble protein extracts
was loaded on 12% SDS-PAGE, blotted and incubated with an anti-
MDA antibody and then with an anti-Rabbit IgG , HRP conjugate.
The bound activity was revealed as above.
– Oxidative DNA damage, was detected in terms of 8-OHdG, by the
OxiSelect Oxidative DNA Damage ELISA Kit (Cell Biolabs, Inc).
Extract DNA from tissues treated with the nuclease P1 was used
for competitive ELISA assay: the samples were ﬁrst added to the
8-OHdG/BSA preabsorbed plates, then incubated with an anti-
8-OHdG antibody, followed by an HRP conjugated secondaryPlease cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
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plate reader.
Histochemistry
DAB-enhanced PrussianBlue stainingwas performed to identify iron
deposition in serial 40 μm coronal mouse brain sections. Brieﬂy, brain
sections were washed twice with PBS, permeabilized with PBS/Triton
0.5% and then incubated for 1 h with 4% potassium ferrocyanide in
6% hydrochloric acid. Then slices were reacted with activated 0.014%
DAB containing 0.03 H2O2 for 10 min and then washed three times
with PBS. DAB staining was acquired with the Nuance Multispectral
Tissue Imaging Systems (PerkinElmer) assembled on Zeiss Axioplan2
microscope and quantiﬁed with the Advanced Image Analysis Software
inForm (PerkinElmer).
Immunoﬂuorescence
Brain slices were washed twice in PBS and incubated with blocking
solution (PBS with 10% FBS and 0,3% Triton X-100) for 1 h at room tem-
perature. Then, tissues were incubated overnight at 4 °C with anti-
ferritin primary antibody (LF03 5 μg/ml) diluted in blocking solution.
Following 3 washes in PBS, cells were incubated with secondary anti-
body in PBS (donkey anti-mouse Alexa 488; Molecular Probes) for
90 min at room temperature. Tissues were also stained for NeuroTrace
530/615 (a neuronal marker, diluted 1:100 in PBS; Molecular Probes)
and TO-PRO-3 (a nuclear marker diluted 1:1000 in PBS; Molecular
Probes). All brain slices were mounted on glass slide using Fluorsave
(Calbiochem) and acquired on confocal microscope (BioRad confocal).
Magnetic resonance imaging (MRI)
For in vivoMRI, mice were anesthetized with gas (2% Isoﬂurane in
oxygen) and brain acquisitions were done with a 7 T MR scanner
(Bruker Biospec 30/70, Ettlingen, Germany) and a 4 channel dedicated
mouse brain phased-array coil.
2D Fast Low Angle SHot (FLASH) Susceptibility Weighted Imaging
(SWI) images [repetition time (TR) = 474.5 ms; echo time (TE) =
15 ms; ﬂip angle (FA) = 30°; number of excitations (NEX) = 10; ﬁeld
of view (FOV) = 2.5 cm; slice thickness/inter-slice distance = 0.6 mm;
acquisition matrix = 512 × 384] and multiecho Rapid Acquisition with
Relaxation Enhancement (RARE) T2 sequence (TR = 3851.8 ms; 16
echoes with TE ranging from 11 to 176 ms; NEX = 2; FOV =
2.5 cm; slice thickness/inter-slice distance = 0.6 mm; acquisition ma-
trix = 198 × 198) were acquired. T2 maps were calculated using the
manufacturer's software (Paravision 5.1). In order to evaluate the
local relaxation times, circular ROIs of the same size (4 ∗ 105 μm2)
over different areas of the brain (cortex, striatum, hippocampus, pons
and cerebellum) were drawn by the same operator on T2 images and
then transferred on T2 maps.
For ex vivo imaging, brain acquisitions were performed on a human
grade 3 T MRI scanner (Achieva 3 T, Philips Medical Systems, the
Netherland) equipped with a mouse dedicated volumetric coil.
The following sequences were: 3D Turbo Spin Echo T2 (TR =
2500 ms; TE = 90 ms; Turbo Spin Echo Factor = 4; NEX = 4;
FOV = 2.5 × 1.2 × 1.2 cm; slice thickness = 0.5 × 0.5 × 0.5 mm;
acquisition matrix = 256 × 128) and SWI (TR = 61 ms; TE 40 ms;
ﬂip angle = 30°; NEX = 28; FOV = 3.5 × 1.9 × 1.4 cm; slice thick-
ness = 0.1 mm; acquisition matrix = 336 × 184).
Electron spectroscopic imaging
The thin sections (~25 nm, gray tone) analyzed by Electron Spectro-
scopic Imaging (ESI)were ﬁrst examined at 250 eV (i.e. at an energy loss
where scattered electrons of most elements contribute to the image),athy mouse model (FTL 498InsTC) shows progressive brain iron...,
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(Pezzati et al., 1997). The pattern of net iron distribution was then ob-
tained by computer-assisted processing of two images collected below
(651 and 683 eV) and one beyond the Fe-L3 absorption edge at
719 eV. The typical energy width of the imaging electrons was−5 eV.
A threshold of iron values was routinely set to exclude random noise
from the ﬁnal representation. The map thus obtained, represented
according to a pseudocolor scale (from dark red to yellow), was
superimposed to the corresponding 250-eV image. The nature of iron
signals in the maps was conﬁrmed by EELS spectra.
Autoﬂuorescence spectra
Since lipofuscin is a native autoﬂuorescent material we tested its
possible presence by exposing brain sections to excitation at two wave-
lengths: 458 and 514 nm in a Leica SP2 confocal microscope. The lamb-
da scan mode was selected and the detection windowwidth was set to
10 nm. The PMT offset was left at 0. The detection window was moved
to the different laser lines and the PMT gain adjusted so that the reﬂec-
tion image at each line was below saturation. AOTF settings for each
laser line were adjusted to obtain similar peak intensities. The lambda
scan was performed in 10 nm intervals (exc. 458, em. 480–700 nm;
exc. 514, em. 540–740).
Recombinant ferritins
The recombinant human ferritin homopolymers and heteropolymers
were produced in Escherichia coli as described in Luscieti et al., 2010. The
heteropolymers were produced by a bicistronic expression vector in
which the sequence of the Ferritin H chain was followed by a ribosome
binding site and by the sequence of the L-chain, wild type or mutated.
This construct produced in E. coli heteropolymers composed by 20–22
H chain and 4–2 L-chains, which are expected to mimic the subunit
composition of the brain ferritin. The proteins were puriﬁed and loaded
with 1000 Fe atoms per molecule before cyclic voltammetry studies.
FtL167fsx26 corresponds to the protein encoded by the 498–499InsTC
mutation.
Cyclic voltammetry
Cyclic voltammetry investigationswere performed to determine the
electrochemical properties of recombinant ferritins (in Tris 30 mM
pH 7.4) and accomplished using a CHI 210B bipotentiostat (CHI Instru-
ment Inc., Texas, USA). All potentials are referred to Ag/AgCl reference
electrode.
We used screen printed gold electrodes (DROPSENS, Llanera, Spain)
designed for electrochemical investigation of small sample volumes in
order to enable the direct characterization of the dissolved proteins.
Using the aforementioned strategy, additional surface adsorption proce-
dures were avoided, that could potentially interfere with the protein
functioning and with the iron release/uptake kinetics (Bard and
Faulkner, 2001)
Primary culture of hippocampal neurons
The hippocampal cultures were prepared from 1–2 d-old transgenic
(Tg)-C57 and wild-type (WT)-C57 mice, according to Codazzi et al.
(2006). Brieﬂy, the hippocampal sections were digested into Hank's so-
lution containing 3.5 mg/ml trypsin type IX (Sigma, St. Louis, MO) and
0.5 mg/ml DNase type IV (Calbiochem, La Jolla, CA) for 5 min and then
mechanically dissociated in a Hank's solution supplemented with
12 mMMg2SO4 and 0.5 mg/ml DNase IV. After centrifugation, the pool
of the neurons obtained from control and transgenic mice were plated
onto polyornithine-coated 96-multi wells andmaintained in MEM sup-
plementedwith 0.3% glucose, B27 supplement, 2mMglutamax, 5% fetal
calf serum, and 3 μM Ara-C (1-D-cytosine-arabinofuranoside) (Sigma).Please cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
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and used from 1 to 2 weeks after plating.
Cell death analysis
Hippocampal neurons were maintained in culture for one to two
weeks. Before the experiment, cells were washed with Krebs Ringer
Hepes buffer (KRH, containing 5 mM KCl, 125 mM NaCl, 2 mM CaCl2,
1.2 mM MgSO4, 1.2 mM KH2PO4 and 6 mM glucose, 20 mM Hepes,
pH 7.4). Cell death and vital analyses were performed by exposing the
cells in Sytox Orange and Hoechst 33342, respectively (5 μM in KRH,
5 min incubation at room temperature). The analysis was performed
by a High Throughput Microscopy (HTM) system, the IN Cell Analyzer
1000 (GE Healthcare, Grandview Blvd, Waukesha, WI, USA).
Behavioral test
Motor coordination and balance were tested using an accelerating
rotarod (Accelerating Rotarod, Ugo Basile, Gemonio, Italy). The rotarod
test was speciﬁcally designed for automated measurements of neuro-
logical deﬁcits in rodents; it allows studying motor coordination using
the natural fear of falling response in mice (Brooks and Dunnett,
2009). Latency to fall is a more stringent measure of ability to maintain
balance, since the requirements for running forward are gradually
increasing. Mice with deﬁcits in motor coordination or balance fall off
the rotarod before the end of the 5-minute test session (Crawley,
1999). Deﬁcits in the rotarod test can be caused by pathology in the
cortex, cerebellum, and spinal cord, in addition to pathology in dopami-
nergic regions such as the substantia nigra and striatum. More in detail,
GABAergic interneurons in the dorsal striatum are seemingly crucial for
facilitating ﬁne movement, as GABAergic dysfunction in the striatum
has been linked with hyperkinetic movements and motor coordination
(Plenz and Kitai, 1998; Do et al., 2013).
Mice were tested at different ages: a) young mice, 2 months-old
(n = 7 male and 7 female WT; n = 8 male and 8 female Tg); b) adult
mice, 8 months-old (n = 18 male and 12 female WT; n = 15 male
and 13 female Tg); c) aged mice, 18 months-old (n = 6 male and 5 fe-
maleWT; n=5male and 5 female Tg). The testwas performed by plac-
ing a mouse on a rotating rod with a diameter of 3 cm and measuring
the latency to fall (in seconds), through a switch placed on the ﬂoor
below. Mice were given three trials each with a maximum time of
300 s (5 min), during which time the rotating rod underwent a linear
acceleration from 4 to 40 rpm over 5 min. Animals were rested a
minimum of 10 min between trials to avoid fatigue and exhaustion
(Paylor et al., 2006).
Statistical analyses
Data, except where otherwise indicated, are reported as the
mean ± SD values or as a representative of at least three indepen-
dent experiments with similar results. Statistically signiﬁcant differ-
ences between CTR and Tg mice were determined by the Student's t
test, at three different level *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
Behavioral data were analyzed using parametric analysis of vari-
ance (ANOVA) with “genotype” (WT and Tg) and “gender” (male and
female) as between-subjects factors and “trial” as within-subject re-
peated measure. Post hoc comparisons were performed by the
Tukey's test. Statistical analysis was performed using Statview II
(Abacus Concepts, CA, USA). Data are expressed as mean ± SEM.
The level of signiﬁcance was set at 0.05.
Experimental procedures and animal care approval
Animal handling and experimental procedures were performed
in accordance with the EC guidelines (EC Council Directive 86/609
1987) and with the Italian legislation on animal experimentationathy mouse model (FTL 498InsTC) shows progressive brain iron...,
Fig. 1.Mutant FtLF167SfsX26 has a reduced capacity to incorporate iron. A 3D representation
of L-ferritin subunit (FtL) and of its mutant (FtLF167SfsX26). Figures were drawn using the
molecular graphics program PyMOL. The model highlights the loss of conformation of
the E-helix (green dashed line) in the mutant protein, with consequent widening of
the channel open to the inner cavity. B The cyclic voltammograms of FtH/FtLF167SfsX26
(red lines) and FtH/FtL protein (black lines) report the current signal (I/μA) measured as
the electrode potential changes (E/V) linearly with 100 mV/s scan rate (see Material and
methods). It shows that the iron catalytic release of FtLF167SfsX26 starts at a lower potential
(~25 mV, see inset: the ﬁrst forward scan background corrected is shown for the two
species). C The graph shows the oxygen reduction currents vs. applied potentials:
FtH/FtLF167SfsX26 produces an augmented reduction current with higher generation
of ROS.
5F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxx(Decreto L.vo 116/92). All the experiments performed at the San
Raffaele Scientiﬁc Institute and at the University of Brescia were ap-
proved by the internal Institutional Animal Care and Use Committees
(IACUC).
Results
Recombinant human mutant FtL (498–499InsTC) shows reduced capacity
to incorporate iron
Our previous results, obtained with recombinant ferritin
heteropolymer, suggested that the presence of a few mutant
L-chain alters the permeability of ferritin and its capacity to retain
iron (Luscieti et al., 2010). Since electron-transfer reactions are in-
volved in the iron loading and unloading of ferritin (Ritzert et al.,
2009), we explored the capacity of mutated ferritin to retain iron
in vitro, by cyclic voltammetry. To this aim, we employed two recom-
binant heteropolymer ferritins constituted by H and L-chains: the
FtH/FtL, which mimics the form present in normal brain and the
FtH/FtL167Sfsx26, the variant form encoded by the 498–499InsTC mu-
tation (Fig. 1A). These ferritins were used to investigate the kinetics
and energies of iron release. We found that the energy of iron release
is different for the FtH/FtL167Sfsx26: compared to the FtH/FtL form, the
iron catalytic release of the mutant specie started at a lower poten-
tial (~25 mV; Fig. 1B). This implies that the iron release from the fer-
ritins containing the mutant L-chain occurs under milder conditions
with a consequent increased iron concentration in the proximity of
the mutant protein. Moreover, the oxidation waves in the cyclic volt-
ammograms show only one peak for the FtH/FtL, at 360 mV, and two
different peaks for the FtH/FtL167Sfsx26, at 300 mV and 480 mV,
respectively (Fig. 1B). These results suggest that also the oxidation/
uptake iron route is modiﬁed by the mutation.
Finally, an electrochemical evaluation of the reactive oxygen species
(ROS) production was performed in the presence of ferritins. Our data
demonstrate that the FtH/FtLF167SfsX26 produces more effectively ROS
species in physiological solutions compared to FtH/FtL. In these mea-
surements, oxygen reduction is related to the generation of ROS. The
graph (Fig. 1C) shows that the oxygen reduction current is 30% higher
for FtH/FtLF167SfsX26 than for the FtH/FtL, proving that in the presence
of the variant ferritin iron is less retained and ROS are more efﬁciently
generated.
Generation of a murine model for the neuroferritinopathy human mutant
FTL (498–499InsTC)
To produce an animal model for neuroferritinopathy, we generated
transgenic mice by pronuclear microinjection in FVB mouse strain
(the standard strain to produce transgenic mice) of the vector for the
human mutant FTL gene (498–499InsTC). The expression of the trans-
gene was driven by the constitutive and ubiquitous PGK promoter
(Fig. 1S, A). The mice were genotyped by PCR using primers to speciﬁ-
cally amplify a 275 bp fragment of the human FTL gene (arrows in
Fig. 1S A and ampliﬁcation band in B); no cross-ampliﬁcation of the
mouse FTL gene or pseudogenes can be detected in WT offsprings
(Fig. 1S, B). Three transgenic lineswere obtained and analyzed for trans-
gene expression by RT-PCR. The transgene transcript was detected in all
tissues analyzed, including brain and liver (not shown). Then, the ex-
pression of the transgenic protein was assessed by ELISA and by immu-
noblotting of non-denaturing PAGEwith amonoclonal antibody speciﬁc
for the assembled human FtL (LF03), that does not cross react with the
endogenous mouse ferritins (Santambrogio et al., 2007). In 3-month-
old mice, the expression of the transgene was high in the liver and
even greater in the brain (Fig. 1S, B). Based on the protein expression
levels, we selected one of the mouse lines for establishing the colony
and for further studies. Transgenic (Tg-FVB) and control FVB (WT-
FVB) mice were followed for up to two years.Please cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
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FTL and oxidative damage
Groups of threeWT-FVB and Tg-FVBmicewere sacriﬁced, the brains
collected and the protein extracts analyzed by ELISA for the expression
of human FtL as well as of the endogenous FtL and FtH at different ages
(3, 6, 12 and ≥18 months). Accumulation of transgenic human FtL in-
creased progressively with age and reached a maximum of about
4 μg/mg of total proteins at 18 months of age (Fig. 2A, upper panel).
Also the accumulation of the soluble endogenousmurine FtL and FtH in-
creased with age, but they reached a maximum at 12 months. At thisathy mouse model (FTL 498InsTC) shows progressive brain iron...,
Fig. 2. Increased expression of mutated human FTL induces elevation of cytosolic iron and oxidative damage in Tg-FVB mice brains. A. The soluble brain homogenate fractions ofWT-FVB
and Tg-FVBmice at different ageswere analyzed for human L-ferritin (upper panel) and endogenous L- andH-ferritins (middle and bottompanel, respectively) content by speciﬁc ELISA. The
values are the means of three experiments performed in triplicate. B 20 μg of brain homogenates of 12-month-old mice were loaded on 12% SDS-PAGE and blotted with an anti TfR1 an-
tibody (the arrow points to the TfR1). Coomassie blue staining (C.B.) of total protein as loading control. Band densities are reported in the lower panel. C Enhanced Prussian Blue (P.B.)
staining of brain soluble homogenates of 12-month-old Tg-FVB mice and WT-FVB siblings (native-PAGE). Coomassie blue staining (C.B.) of ferritin protein as loading control. The histo-
gram shows the iron incorporation capacity of the ferritin in the two groups of animals as the ratio between the total ferritin iron and the ferritin protein content in the same brain extract.
D The carbonilated proteins of brain homogenate of 12-month-oldWT-FVB and Tg-FVBwere revealed by treatingwith DNPHand blottingwith anti-DNP antibody as described inMaterial
and methods. Band densities are expressed as values relative to the mean of the controls of three independent experiments *p ≤ 0.05.
6 F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxxtime point, Tg-FVB brains showed 2.5 and 3.1 fold higher levels of FtL
and FtH than WT-FVB, respectively (Fig. 2A, middle and lower panels).
Immunoblotting analysis of the Transferrin Receptor 1 (TfR1) showed
in the brain of Tg-FVB mice a signiﬁcant reduction (~58%, **p ≤ 0.001;
Fig. 2B) that was paralleled by that of mRNA level (~50% reduction,
*p ≤ 0.05; obtained by qRT-PCR, not shown). The increase in endoge-
nous ferritin and the concomitant decrease in TfR1 indicate the highPlease cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
Neurobiol. Dis. (2014), http://dx.doi.org/10.1016/j.nbd.2014.10.023availability of intracellular iron, a condition that is line with our experi-
mental evidence that iron is not properly retained inside the cavity of
variant ferritins.
We analyzed total ferritin iron and ferritin protein on the same brain
extracts. This was done by staining non-denaturing PAGE with en-
hanced Prussian Blue and with Coomassie blue (Fig. 2C). The analysis
of the band densities clearly indicates that the iron/protein ratioathy mouse model (FTL 498InsTC) shows progressive brain iron...,
7F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxx(Fig. 2C) was lower in Tg-FVB than in WT-FVB mice, indicating a re-
duced capacity of the ferritin in the Tg mice to incorporate iron in vivo.
Since this condition is expected to promote oxidative damage, we eval-
uated the oxidative status of brain tissues by OxyBlot. The transgenic
mice showed a higher level of carbonylated proteins already at
6 months (not shown) and reached a two fold increase at 12 months
(Fig. 2D, *p ≤ 0.05).
Tg-FVB mice show iron and ferritin accumulation in the brain
The pathologic hallmark of the human disease is the accumulation of
iron and ferritin bodies in the brain and other tissues, with late onset
neurological symptoms. Based on this premise, brain from old mice
were investigated for iron and ferritin content. First, we evaluated iron
accumulation in wild-type and transgenic mice in vivo by MRI. The
MRI changes associated with iron deposition were investigated in
Tg-FVBmice at 18 and 22 months of age asmodiﬁcation of the signal in-
tensity in T2-weighted images (Fig. 3A, left panel, upper row) and in
SWI images (Fig. 3A, left panel, lower row). In all Tg-FVBmice, an overall
darker appearance could be observed at the level of the cortex andFig. 3. Iron accumulation inwhole brain of FVBmutatedmice. AMRI brain examination of 18 an
(lower row) coronal images are shown. Areas of brain iron accumulation are detected in vivo as
analyzed ex vivo, Fast Spin Echo T2 (upper row) and SWI (lower row) images conﬁrm the results
pus, brain cortex and basal ganglia. B In vivo T2 relaxation times of WT- and Tg-FVB mice at 18
reduction of the T2 decay in the brains of Tg mice with respect to the control, in particular in s
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tion. Further, several hypointense spots highly evocative of iron aggre-
gation could be detected on SWI images in the striatum and
Hippocampal cortex of 18 and 22 month-old Tg-FVB mice, but not in
age-related WT mice. Using T2 relaxometry, in vivoMRI T2 maps were
generated and showed a signiﬁcant decrease in the T2 decay, a param-
eter that is well known to correlate with iron deposition, in the frontal
cortex, striatum, hippocampus, pons and cerebellum of Tg-FVB mice
(Fig. 3B, *p≤ 0.05; **p≤ 0.01; ***p≤ 0.001). As expected, these obser-
vationswere corroborated by ex vivoMRI analyses which conﬁrmed the
presence of the above described hypointense areas on high resolution
3D T2 and SWI sequences (Fig. 3A, right panel). These data most likely
indicate the increased level of iron in the brain of livingmice expressing
mutant FTL.
To verify that iron accumulates in mutant brains, we performed his-
tochemical analysis of iron by DAB-enhanced prussian blue stain. DAB-
stained sections of 18 and 22 month-old mutant brains showed a large
increase in the number of brown positive precipitates over controlmice,
with no signiﬁcant variations between the two ages (Fig. 4A). This result
indicates iron accumulation when the human transgene is expressed.d 22 month-old controls and transgenic FVBmice. Left panel: RARE T2 (upper row) and SWI
multiple small dark hypointense areas. Right panel: the brain from the same animals were
obtained in vivo and show the presence of iron accumulation at the level of the hippocam-
and 22 months of age measured on T2 maps. These measurements revealed a signiﬁcant
triatum, hippocampus, cerebellum and pons, highly suggestive of iron accumulation.
athy mouse model (FTL 498InsTC) shows progressive brain iron...,
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Fig. 5.MRI reveals that brain iron accumulation increases during aging. In vivo T2 relaxation times of Tg- and WT- C57 mice at 6, 12 and 18 months of age measured on T2 maps. At
6 months a trend of T2 reduction was observed in the brains of Tg mice, but this reduction became signiﬁcant at 12 and 18 months of age at the level of the striatum and pons
(*p ≤ 0.05; **p ≤ 0.01; ***p≤ 0.001).
9F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxxBrain sectionswere also decoratedwith amonoclonal antibody for hFtL,
Neurotrace as a neuronal marker and TO-PRO-3 for nuclei. The images
show the presence of aggregates of human ferritin inside neurons in
Tg-FVB mice at both 18 and 22 months (Fig. 4B).Transgenic mice in the C57BL/6 J background show lower accumulation of
iron and ferritin but maintain oxidative damage
To perform behavioral analysis, we backcrossed transgenic FVB
strain with C57BL/6J (C57) mice for N6 generations (see Material and
methods) to obtain an incipient congenic strain where the mutant FTL
is stably expressed. The C57 strain is widely used in behavioral studies
to investigate motor and higher brain functions. We initially found
that the transgene ferritin was expressed at detectable level in the
brain of the 12-month-old Tg-C57mice (n=4) (Fig. 1S, C), but, surpris-
ingly, its accumulation was much lower than that found in the FVB
strain with the same transgene (Fig. 2A upper panel). This occurred at
both the transcript (not shown) and the protein level (~90% and ~93%
decrease, respectively) compared to Tg-FVB brains. MRI was performed
in vivo and nohypointense spots could be observed in SWI images of the
Tg-C57 brains (not shown). However, MRI T2 maps showed a decrease
in T2 relaxation times and an increase in the R2 in the brains of older
transgenic mice, suggestive of diffuse neuronal iron deposition: a
signiﬁcant T2 reduction was measured in striatum and pons of 12 and
18-month-old mice compared to age matched controls (Fig. 5,
*p ≤ 0.05; **p ≤ 0.01; ***p. ≤ 0.001). Of note, the serum endogenous
ferritin levels halved in transgenic mice (from 775 ± 160 vs 351 ±
139; n = 4), in a way similar to what observed in neuroferritinopathy
patients (McNeill et al., 2008). We then evaluated signs of increased
oxidative damage. We compared brain tissues from Tg-C57 with thoseFig. 4. Ferritin and iron accumulation in section of the brain of FVB mutated mice. A DAB-enha
mice. The iron accumulation is documented by brown dots. The number of these dotswas quant
(*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001). B Immunoﬂuorescence analyses of the same brains pe
TO-PRO-3 (nuclearmarker, blue). In Tgmice an increase in L-ferritin positivity with respect to c
Higher magniﬁcations are shown in the two inserts.
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(OxyBlot; **p ≤ 0.001, Fig. 6A); higher levels of protein ubiquitination
(immunoblotting; *p ≤ 0.05, Fig. 6B); higher lipidic peroxidation
(oxy-MDA, *p ≤ 0.05, Fig. 6C) in Tg-C57 mice respect to the WT-C57.
Furthermore, the evaluation of 8-OHdG resulted in higher levels of
DNA oxidation (1,68 fold, *p ≤ 0.05) respect to the control mice (not
shown). The altered oxidative status was also conﬁrmed by a 1.5-fold
increase (*p ≤ 0.05) in Tg-C57 mice of the expression of catalase, one
of the early defense response to altered oxidative conditions (Fig. 6D).Primary cultures of hippocampal neurons from Tg mice show increased
susceptibility to oxidative stress
Based on the correlation of iron accumulation and oxidative stress
observed in Tg-FVB and Tg-C57 brains, hippocampal cultures were ob-
tained from both WT- and Tg-C57 mice. These preparations were sub-
jected to different oxidative stress conditions to mimic, in a very short
period of time, what it might occur to neurons during their lifespan. In
particular, the susceptibility of neurons to the oxidative insults was
evaluated in conditions of chronic iron overload (100 μM ferric iron, ad-
ministered as ferric ammonium citrate, for 24 h) and/or after acute ex-
posure to hydrogen peroxide (300 μM, added immediately before the
experiment). The kinetic analysis of cell death was performed by high
throughput microscopy (Pelizzoni et al., 2011), an approach that
allowed to partially overcome the high variability of themeasurements,
largely due to the fact that in the neuronal preparations several hippo-
campi from littermates with mixed genotype were pooled due to
technical restrictions. For all oxidative conditions, a toxic effect over
time is demonstrated by the increasingpercentage of Sytox-positive nu-
clei (a marker of cell death); however, this effect was clearly higher innced Prussian Blue staining of brains of 18 and 22 month-old controls and transgenic FVB
iﬁed, revealing a signiﬁcant increase in iron deposits in Tgmice of 18 and 22 months of age
rformed with anti hFtL (LF03 green) antibody, Neurotrace (neuronal staining, red) and
ontrol micewas detected indicating an accumulation of protein aggregates inside neurons.
athy mouse model (FTL 498InsTC) shows progressive brain iron...,
Fig. 6. Tg-C57 brains maintain oxidative damage. Soluble fractions of brains ofWT-C57 and Tg-C57 12-months-old were analyzed on 12% SDS-PAGE, subjected to immunoblotting. A The
oxidized proteins (1 μg)were detected by treatingwith DNPH and blotted with anti-DNP antibody. B After electrophoretic analysis, 20 μg of brain homogenateswere blottedwith an anti-
ubiquitin antibody. C 10 μg of soluble proteins of homogenatewere tested forMDA–protein adductsmeasured by theOxiSelectMDA immunoblot Kit. D 25 μg of total soluble proteinswas
blotted and incubated with an anti-catalase antibody. Immunoblotting shows one representative of three independent experiments. Quantiﬁcation of band area was performed by den-
sitometry and expressed as % of WT; results are the mean of three independent experiments.
10 F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxxthe neurons from Tg-C57 than in those fromWT-C57matings (Fig. 7A).
The statistical analysis of the number of dead cells at the end of the ex-
periments (90 min) shows a signiﬁcant difference between the two
populations, analyzed after both 7 and 14 days in culture (Fig. 7B), indi-
cating an increased susceptibility for oxidative damage of neural popu-
lations enriched for mutant FtL in respect with pure WT neurons.Please cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
Neurobiol. Dis. (2014), http://dx.doi.org/10.1016/j.nbd.2014.10.023Tg-C57 mice show iron and lipofuscin accumulation
Brain tissues were investigated at the ultrastructural level for
possible histologic hallmarks of neurodegeneration as early signs of a
developing neuroferritinopathy; the presence of these signs is essential
to assess the suitability of our animal model to investigate earlyathy mouse model (FTL 498InsTC) shows progressive brain iron...,
Fig. 7.Primary hypocampal neurons fromTg-C57mice show increase susceptibility to oxidative stress. A Kinetic datawere recorded from3 independent experiments for each genotype, in
duplicate (1000 cells per condition). Chronic iron overload was performed by 24 hour treatments with 100 μM ferric ammonium citrate (24 h FAC), while hydrogen peroxide (H2O2,
300 μM) was administered immediately before starting the image acquisition. The bars represent the standard errors. B The percentage of cell death was analyzed under the indicated
conditions at the end point of the kinetics. Statistical signiﬁcance was tested using two-way ANOVA followed by Bonferroni post hoc test. **p ≤ 0.01; ***p ≤ 0.001. DIV = days in vitro.
11F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxxpathogenetic events of the disease. The presence of relatively small,
membrane bounded and vacuolated, osmophilic bodies was detected
in 12 month-old mice (Fig. 8A). However, they were more abundant
in Tg-C57 than in WT-C57 mice (about one order of magnitude in the
average).Moreover,while their regional distributionwas homogeneous
in WT brains, a higher density (about 3 folds) was observed in the stri-
atum of Tg mice. The ultrastructural localization of these osmophilic
bodies was cytoplasmatic with no evidence of their presence in either
the nucleus or extracellularly. They were typically composed of a gran-
ular matrix, with irregularly distributed dark-black dots, and a vesicle
with a clear inner matrix.
The presence of these osmophilic bodies has long been reported in
anatomical and histochemical studies and referred to as lipofuscin gran-
ules, i.e. pigment granules containing lipid residues of the lysosomal di-
gestion and metals. Accordingly, we employed electron spectroscopic
imaging (ESI), a techniquewhich allows high resolution elemental anal-
ysis of thin sections, to look for the presence of iron. In Fig. 8B, a pair of
pictures are presented where the image to the left illustrates the ultra-
structural organization at 240 eV (i.e., below the carbon K-edge), and
that to the right shows the same image with superimposed the ESI
iron distribution (coded from dark to light red, low to high values,
respectively). The ESI analysis of brain tissue revealed high iron signals
within the granular matrix and the dense dots. No comparable signals
where observed in other subcellular compartments.
To further conﬁrm the presence of lipofuscin in these osmophilic
bodies, we studied their autoﬂuorescence properties. The emission of
ﬂuorescence from putative lipofuscin granules was excited at three
wavelengths (458, 514 and 543 nm). With increasing excitation wave-
length, the emission maximum shifted towards longer wavelengthsPlease cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
Neurobiol. Dis. (2014), http://dx.doi.org/10.1016/j.nbd.2014.10.023and spectral width (Fig. 8C) was decreased as previously reported for
lipofuscin accumulations in the retina (Sparrow, 2010).
Tg-C57 mice develop a motor coordination impairment with aging
As a ﬁnal characterization of our model of neuroferritinopathy, we
evaluated themotor coordination by using the natural fear of falling re-
sponse. The rotarod test revealed a signiﬁcant effect of trials in young
(main effect of trial F(2,52)= 16.884, ***p≤ 0.0001), adult (main effect
of trial F(2,108) = 36.772, ***p ≤ 0.0001) and old (main effect of trial
F(2,34) = 4.730, *p ≤ 0.05) mice showing a typical training curve.
Analysis of motor performance of transgenic mice on the rotating rod
revealed nodifference in the latency to fall either at the earliest age test-
ed, (2 months) (no main effect of genotype F(1,26) = 1.803,
p ≤ 0.1909) or in the adult group (no main effect of genotype
F(1,54) = 0.406, p ≤ 0.5267). Regardless of gender, at 18 months of
age Tg-C57 mice fell earlier from the apparatus compared to wild-type
subjects (main effect of genotype F(1,17)= 15.317, **p≤ 0.001 and in-
teraction between genotype and trials F(2,34) = 3.255, *p ≤ 0.05), an
effect suggesting impaired motor coordination building up with age
(Fig. 8D). Interestingly, female Tg-C57 subjects in trial 3 performed bet-
ter than males, although not signiﬁcantly, indicating a less penetrant
phenotype in females at old age (interaction among trial, genotype
and gender F(1,34) = 2.934, p ≤ 0.0668).
Discussion
Alteration of cellular oxidative status is a main determinant in neu-
rodegeneration (Rouault, 2013), and iron excess is one of the principalathy mouse model (FTL 498InsTC) shows progressive brain iron...,
12 F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxx
Please cite this article as: Maccarinelli, F., et al., A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron...,
Neurobiol. Dis. (2014), http://dx.doi.org/10.1016/j.nbd.2014.10.023
13F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxxcauses of oxidative stress (Halliwell and Gutteridge, 1992). However,
the interplay among iron, oxidative damage and neurodegeneration is
not fully understood. Neuroferritinopathy constitutes an interesting
pathogenic model to study the interplay among all these factors. Previ-
ous studies on patients' autoptic samples (Curtis et al., 2001; Baraibar
et al., 2012) as well as on animal (Vidal et al., 2008; Barbeito et al.,
2009) and cellular models (Barbeito et al., 2010; Cozzi et al., 2006,
2010) have suggested a few elements as key factors involved in the
etiopathogenesis of the disease: i) alteration of iron metabolism, ii)
increased oxidative stress and iii) formation of aggregates of iron and
ferritin. To prove that these events are interrelated and that their
concomitant action leads to neuronal death, we generated two new
transgenic mouse models overexpressing the 498–499InsTC human
ferritin mutant, under the PGK promoter, in FVB and in C57 strains.
This latter mouse model is analogous to that described by Vidal (Vidal
et al., 2008), but the transgene is under the PGK promoter instead of
the Prion protein one used by Vidal (Vidal et al., 2008). Notably, the
prion protein promoter has a much more neuron-selective and power-
ful expression than the PGK promoter (Borchelt et al., 1996). Hence our
C57mousemodel, characterized by amore attenuated and, thus, amore
physiological expression of the mutant FTL gene, might better recapitu-
late the human disease.
Although the transgene was expressed in all tissues tested, we
focused our analysis on the brain, the organ inwhich neuroferritinopathy
is pathogenic. The expression of the transgene product progressively
increasedwith age andwas paralleled by an elevation of the endogenous
ferritins and down-regulation of TfR1. This response is consistent with an
elevation of free cytosolic iron, a condition that modulate, in an opposite
way, ferritins and TfR1 translation, via the IRE/IRPs machinery. Therefore
these data strongly suggest that the increase in ferritin levels leads to a
decrease in iron buffering capacity and not in an elevation, as it
would be expected in conditions of overexpression of the native protein
(Cozzi et al., 2000).
Based on this premise, we hypothesized that the biophysical proper-
ties of the transgenic ferritin in storing ironwere altered. To address this
point, we investigated recombinant ferritins at the molecular level. A
critical issue might be the composition of different subunits in the
shell. As previously demonstrated in vitro (Luscieti et al., 2010) and as
expected by the dominant transmission of the disease, a low percentage
of the variant peptide is sufﬁcient to strongly reduce the capacity of fer-
ritin to incorporate iron. Accordingly, we produced heteropolymer ferri-
tins characterized by a high proportion of H chains (21–22 per 24-mer)
and a low proportion of the FtL WT or the FtL167Sfsx26.
Cyclic voltammetry analysis revealed that the variant ferritin facili-
tates the release of iron from the shell thereby reducing the overall
capacity to retain iron within the inner cavity.
The lower ability of the mutated protein to buffer iron can account
for the elevation of the iron reported in patients brains and documented
by the MRI and by the presence of granules of ferritin and iron in the
autoptic samples (Curtis et al., 2001; Baraibar et al., 2012). A very similar
condition was observed in the brain of the aged transgenic mice, which
showed hypodense areas at theMRI, typical signs of an accumulation of
hemosiderin and ferritin within tissues (Robinson and Bhuta, 2011). In
particular, in the FVB mutant mice, both T2 and SWI MRI sequences
demonstrated the in vivo presence of multiple small dark hypointense
areas in the basal ganglia and hippocampi highly suggestive for sites
of iron accumulation. MRI T2-relaxometry is a sensitive technique forFig. 8. Tg-C57 mice show iron and lipofuscin accumulation and behavioral alteration. A A co
(arrowheads) characterized by the presence of a granularmatrix, containing irregularly distribu
on the right). These bodies were typically localized close to the nucleus. B Subcellular iron ma
250 eV (represented with inverted gray tone values). On the right, the same image with super
(low to high iron content). Iron appears to be concentratedwithin the granular matrix of the os
tigated upon excitation at two excitation wavelengths: 458 and 514 nm.With increasing excita
width was decreased as previously reported for lipofuscin accumulations. D Assessment of mot
dination compared to wild-type subjects. Results are presented as mean + S.E.M. * p ≤ 0.05; (
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employed for iron load quantiﬁcation in different neurological
disorders, including PKAN, multiple sclerosis an Parkinson's disease
(Zorzi et al., 2011; Khalil et al., 2009; Mondino et al., 2002) as well as
in neuroferritinopahy (McNeill et al., 2008). A signiﬁcant accumulation
of iron within the striatum, hippocampus and pons was further
conﬁrmed, ex vivo, by the presence of histochemical positivity for iron.
The number and size of the Fe3+-positive granules increased with age,
in parallel with the accumulation of the exogenous ferritin, mainly
localized in neurons.
Additional information was provided by the elemental analysis at
the ultrastructural level that revealed iron accumulation within the
granular matrix of osmophilic bodies. These bodies were membrane
bound and contained vacuolated areas with a clear inner matrix;
ﬂuorescence spectral analysis provided conclusive evidence that these
granules were lipofuscin and not neuromelanin granules, although
they share similar morphology (Double et al., 2008). Notably, although
iron aggregates were typically localized close the nucleus, we never
observed any nuclear accumulation of this ion. This is at variance with
whatwas reported in the previousmousemodel for the samemutation;
a reason for this discrepancy may be related to the lower expression of
the transgene in our mutant mice (Vidal et al., 2008). However, lack of
elemental analysis in the article from the Vidal laboratory makes difﬁ-
cult to compare these morphological aspects.
All our ﬁndings point to an altered kinetics of iron uptake/release of
the FtH/FtLF167SfsX26, which are expected to result in higher availability
of free iron. In turn, higher levels of cytoplasmic iron are expected to
promote the Fenton reactionwhose end-products are ROS. This dynam-
ics is supported by molecular evidence in vitro, where the higher
availability of iron around the electrodes coated with the mutated FtL
protein caused, in the buffer solution, a potent increase in ROS. We
substantiated this observation with conclusive evidence of increased
ROS production and of oxidative damage in the brain tissue derived
from our transgenic mice by dosing oxidation of proteins, lipids, and
nucleic acids with a variety of techniques. Notably, primary neuronal
cultures derived from our mouse model showed an increased suscepti-
bility to iron-induced-death, thus providing strong evidence that the
basal oxidative stress is coupled with a reduced antioxidant cellular
defense, a condition which actively cooperates in cell damage. Along
this line is the observation of an the increased presence of lipofuscine
granules. In fact, lipofuscin is a well-known hallmark of aging, hence
its alternate name of “age pigment”, and the rate of its accumulation is
reported to correlate negatively with longevity (Brunk and Terman,
2002). A number of experimental evidence have previously linked
lipofuscine accumulation with oxidative stress. In particular, it has
been reported that the oxidation of 26S proteasome by a variety of
altered pathways (Reinheckel et al., 2000) promotes its disassembly
(and consequent accumulation of polyubiquitinated proteins (Wang
et al., 2010). This occurrence starts a cascade of events that ultimately
leads to the formation of lipofuscin-containing aggregosomes (Hohn
and Grune, 2013). Interestingly, iron has been described as an activator
of lipofuscine formation and amajor component of these aggregosomes
(Brunk and Terman, 2002). Lipofuscine accumulates within the
lysosomes where the degradation of iron-containing proteins, such as
cytochromes and ferritin, leads to the release of redox-active free iron.
Then, lipofuscine is able to adsorb ferrous iron thus constituting a
redox-active surface that catalyzes the Fenton reaction with generationnventional representation of the ultrastructural organization shows osmophilic bodies
ted dark-black dots, and a vacuolewith a clear innermatrix (see two blow up in the insets
p obtained by ESI. The image on the left shows the ultrastructural organization as seen at
imposed the net iron map represented by pseudocolors, ranging from dark red to yellow
mophilic bodies. C The autoﬂuorescence properties of these osmophilic bodies were inves-
tion wavelength, the emissionmaximum shifted towards longerwavelengths and spectral
or function using the rotarod test. Aged Tg mice (18 months) showed poorer motor coor-
n = 11WT, 10 Tg). Data from earlier ages showed no signiﬁcant impairment in this test.
athy mouse model (FTL 498InsTC) shows progressive brain iron...,
14 F. Maccarinelli et al. / Neurobiology of Disease xxx (2014) xxx–xxxof hydroxyl radicals and ampliﬁcation of the oxidative damage (Hohn
and Grune, 2013). Within this framework, the concomitant overloading
of the proteasome by all oxidized proteins, might favor a diversion of all
ferritins, including their oxidized products, towards the aggregosomes
in a self maintained circle of harmful events. The lysosome, overloaded
by lipofuscine, may undergo rupture with direct cell damage by hydro-
lytic enzymes and indirect adverse effects of lipofuscine release into
cytosol, where it may act as a catalyst for further iron precipitation by
enhancing the formation of ferritin–iron aggregates (Fig. 9).
Froma phenotypic point of view, our data indicate that FTL transgen-
ic mice recapitulate not only some pathological signs of human
neuroferritinopathy but also some initial neurological signs associated
with the disease. In particular, higher accumulation of iron aggregates
in the striatum, which is almost exclusively composed of GABAergic
neurons, strictly correlates with the defects in motor coordination
observed by the rotarod test. These defects were somewhat expected
as a direct effect of a dysfunction of the basal nuclei. Furthermore, we
scored a progressive worsening of the motor coordination parameters
with age, with only 18-month-old Tg mice falling from the rotating
rod before controls.Conclusion
We can conclude that our transgenic neuroferritin model recapitu-
lates some key pathological and clinical aspects of the initial phases of
human neuroferritinopathy, including initial CNS pathological
hallmarks and motor coordination deﬁcits. Hence, the molecularFig. 9. Scheme of lipofuscine formation pathway. Themutation in ferritin structure induces high
degradation. Enhanced LIPpromotes ferritin synthesis andROS formationwith consequent prot
favored ferritin/iron aggregation with lysosomal degradation and lipofuscine accumulation. Fol
ritin/iron aggregation.
Please cite this article as: Maccarinelli, F., et al., A novel neuroferritinop
Neurobiol. Dis. (2014), http://dx.doi.org/10.1016/j.nbd.2014.10.023characterization of this model provides new and relevant insights on
the biochemical defects at the basis of the disease, pointing to the oxida-
tive stress as the major molecular effector in the etiopathogenesis of
neuroferritinopathy. Overall, our mutants represent a universal model
for studying speciﬁc therapies aimed to counteract the adverse effects
of oxidative stress in the brain, not only in NBIA disorders, but also in
a vast group of disorders characterized by ROS production and neurode-
generative processes, including Parkinson and Alzheimer diseases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nbd.2014.10.023.Acknowledgments
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